Cargando…

Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis

BACKGROUND/AIMS: Therapies involving bone-marrow-derived mesenchymal stem cells (BM-MSCs) have considerable potential in the management of hepatic disease. BM-MSCs have been investigated in regenerative medicine due to their ability to secrete various growth factors and cytokines that regress hepati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jang, Yoon Ok, Jun, Baek Gyu, Baik, Soon Koo, Kim, Moon Young, Kwon, Sang Ok
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Association for the Study of the Liver 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4493357/ https://www.ncbi.nlm.nih.gov/pubmed/26157751 http://dx.doi.org/10.3350/cmh.2015.21.2.141

Ejemplares similares

Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model
por: Jang, Yoon Ok, et al.
Publicado: (2014)

Ferulic Acid Combined With Bone Marrow Mesenchymal Stem Cells Attenuates the Activation of Hepatic Stellate Cells and Alleviates Liver Fibrosis
por: Zhang, Rui, et al.
Publicado: (2022)

Inhibition of hepatic stellate cell proliferation by bone marrow mesenchymal stem cells via regulation of the cell cycle in rat
por: QIN, SHANYU, et al.
Publicado: (2012)

Pharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic Fibrosis
por: Schon, Hans-Theo, et al.
Publicado: (2016)

Expression of Fibroblast Growth Factor 21 and β-Klotho Regulates Hepatic Fibrosis through the Nuclear Factor-κB and c-Jun N-Terminal Kinase Pathways
por: Lee, Kyong Joo, et al.
Publicado: (2018)

Generation of Fibrotic Liver Organoids Using Hepatocytes, Primary Liver Sinusoidal Endothelial Cells, Hepatic Stellate Cells, and Macrophages
por: Yoon, Yongdae, et al.
Publicado: (2023)

Bone Marrow Stem Cells Anti-liver Fibrosis Potency: Inhibition of Hepatic Stellate Cells Activity and Extracellular Matrix Deposition
por: Sitanggang, Ervina Julien, et al.
Publicado: (2017)

Apamin suppresses biliary fibrosis and activation of hepatic stellate cells
por: Kim, Jung-Yeon, et al.
Publicado: (2017)

Osthole ameliorates hepatic fibrosis and inhibits hepatic stellate cell activation
por: Liu, Ya-Wei, et al.
Publicado: (2015)

Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
por: Zhao, Yuan-Quan, et al.
Publicado: (2023)

Mesenchymal Stem Cells Influence Activation of Hepatic Stellate Cells, and Constitute a Promising Therapy for Liver Fibrosis
por: Lee, Chanbin, et al.
Publicado: (2021)

12-O-tetradecanoylphorbol-13-acetate Reduces Activation of Hepatic Stellate Cells by Inhibiting the Hippo Pathway Transcriptional Coactivator YAP
por: Kim, Chang Wan, et al.
Publicado: (2022)

Clusterin Attenuates Hepatic Fibrosis by Inhibiting Hepatic Stellate Cell Activation and Downregulating the Smad3 Signaling Pathway
por: Seo, Hye-Young, et al.
Publicado: (2019)

Hepatic stellate cells and parasite-induced liver fibrosis
por: Anthony, Barrie, et al.
Publicado: (2010)

Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
por: Khomich, Olga, et al.
Publicado: (2019)

Bone marrow-derived mesenchymal stem cells inhibit the proliferation of hepatic stellate cells by inhibiting the transforming growth factor β pathway
por: ZHANG, LI-TING, et al.
Publicado: (2015)

Rifaximin and Propranolol Combination Therapy Is More Effective than Propranolol Monotherapy for the Reduction of Portal Pressure: An Open Randomized Controlled Pilot Study
por: Lim, Yoo Li, et al.
Publicado: (2017)

Bevacizumab Attenuates Hepatic Fibrosis in Rats by Inhibiting Activation of Hepatic Stellate Cells
por: Huang, Yangqing, et al.
Publicado: (2013)

Bone marrow‐derived macrophage contributes to fibrosing steatohepatitis through activating hepatic stellate cells
por: Han, Juqiang, et al.
Publicado: (2019)

Human placental mesenchymal stem cells ameliorate liver fibrosis in mice by upregulation of Caveolin1 in hepatic stellate cells
por: Yao, Yunqi, et al.
Publicado: (2021)

Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis
por: Kitano, Mio, et al.
Publicado: (2016)

Succinate as a Regulator of Hepatic Stellate Cells in Liver Fibrosis
por: Cho, Eun-Hee
Publicado: (2018)

Hepatic stellate cell hypertrophy is associated with metabolic liver fibrosis
por: Hoffmann, Céline, et al.
Publicado: (2020)

Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Phloretin Ameliorates Succinate-Induced Liver Fibrosis by Regulating Hepatic Stellate Cells
por: Le, Cong Thuc, et al.
Publicado: (2023)

Crosstalk between NK cells and hepatic stellate cells in liver fibrosis
por: Zhang, Yang, et al.
Publicado: (2022)

Fuzheng Huayu Capsule Attenuates Hepatic Fibrosis by Inhibiting Activation of Hepatic Stellate Cells
por: Wu, Mei, et al.
Publicado: (2020)

Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
por: Li, Wenhao, et al.
Publicado: (2020)

Selonsertib Inhibits Liver Fibrosis via Downregulation of ASK1/MAPK Pathway of Hepatic Stellate Cells
por: Yoon, Young-Chan, et al.
Publicado: (2020)

High Dietary Sodium Intake Assessed by Estimated 24-h Urinary Sodium Excretion Is Associated with NAFLD and Hepatic Fibrosis
por: Huh, Ji Hye, et al.
Publicado: (2015)

Hepatic Stellate Cells and Hepatocarcinogenesis
por: Barry, Anna E., et al.
Publicado: (2020)

Gypenosides Synergistically Reduce the Extracellular Matrix of Hepatic Stellate Cells and Ameliorate Hepatic Fibrosis in Mice
por: Li, Han, et al.
Publicado: (2023)

Neutrophil–Hepatic Stellate Cell Interactions Promote Fibrosis in Experimental Steatohepatitis
por: Zhou, Zhou, et al.
Publicado: (2018)

Targeted Drug Delivery to Hepatic Stellate Cells for the Treatment of Liver Fibrosis
por: Chen, Zhijin, et al.
Publicado: (2019)

Inhibition of 5-Lipoxygenase in Hepatic Stellate Cells Alleviates Liver Fibrosis
por: Pu, Shiyun, et al.
Publicado: (2021)

Does CB-1 in hepatic stellate cells contribute to liver fibrosis?
por: Lotersztajn, Sophie, et al.
Publicado: (2022)

Roles of hepatic stellate cells in NAFLD: From the perspective of inflammation and fibrosis
por: Wang, Man, et al.
Publicado: (2022)

Targeting glutamine metabolism in hepatic stellate cells alleviates liver fibrosis
por: Yin, Xiaochun, et al.
Publicado: (2022)

Biomarker microfibril-associated glycoprotein 4 for non-invasive diagnosis and therapeutic evaluation of hepatic fibrosis in patients with hepatitis C
por: Eom, Young Woo, et al.
Publicado: (2019)

Mesenchymal stem cell therapy for liver fibrosis
por: Eom, Young Woo, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ivk0aj41h03u41dof2uase2952